Recent News

• 06.23.2025 - Alaunos Therapeutics Announces $2.0 Million Registered Direct Offering

Recent Filings

• 06.10.2025 - 8-K Current report
• 05.23.2025 - 8-K Current report
• 05.21.2025 - DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material
• 05.21.2025 - DEF 14A Other definitive proxy statements
• 05.21.2025 - ARS Annual Report to Security Holders
• 05.15.2025 - 10-Q Quarterly report [Sections 13 or 15(d)]
• 05.14.2025 - SCHEDULE 13D General Statement of Acquisition of Beneficial Ownership
• 05.09.2025 - PRE 14A Other preliminary proxy statements
• 04.30.2025 - 10-K/A Annual report [Section 13 and 15(d), not S-K Item 405]
• 04.18.2025 - 8-K Current report